episcleritis and scleritis
TRANSCRIPT
Episcleritis
Scleritis&
Panit cherdchu, M.D.
上強膜炎
強膜炎
REFERENCE参照
CONTENT• Review anatomy• Episcleritis vs Scleritis• Episcleritis in depth• Scleritis in depth• Take home message
コンテンツ
ANATOM
Y解剖学 ( レビュー )
Sclera• Type1 collagen and proteoglycans (decorin, biglycan
and aggrecan)• Elastin and glycoproteins (fibronectin)• Fibroblast lie along collagen bundles• Supply by long posterior ciliary nerves at anterior sclera• More translucent when thinning occurs or the water
content changes, falling below 40% or rising above 80%• Thinnest at insertion of rectus muscles
強膜
• Sensory innervation from the ciliary nerves – short posterior ciliary
nerves the posterior portions
– two long posterior ciliary nerves the anterior region.
• Extraocular muscles are inserted into the sclera
• Dull ache of scleral inflammation is made worse by ocular movement
• The sclera itself is avascular• Anteriorly– the anterior ciliary arteries
• Posteriorly– four vortex veins drain the choroidal circulation
Episcleritis
ScleritisVS
Panit cherdchu, M.D.
上強膜炎
強膜炎
Classificationepiscleritis scleritisSimple or diffuse Anterior scleritis
-nodular type-diffuse type-necrotizing with inflammation-necrotizing without inflammation (Scleromalacia Perforan)
Nodular Posterior scleritis
backgroundEpiscleritis scleritis
• Not very common condition
• Self-limiting• asymptomatic• No predominance of
male or female in adult• Predominance of male
in children
• Various presentation• 40-60 years of age• 25-50% of scleritis are
from systemic diseases• Affects more in women
than men (1.6:1)• May follows ocular
surgery
Pathogenesis and risk factorsEpiscleritis Scleritis
•Idiopathic, collagen vascular disease •Self-limited benign inflammation without destructive (not sight-threatening)
• Disordered immune response
• Immune complex deposition (type III hypersensitivity)
• Post surgery scleritis has 96% chance of presented necrotizing scleritis (cataract,pterygium Sx)
• Possibly from infection,trauma,endogenous substance
Episcleritis Scleritis•Abrupt -Days to weeks•Redness without irritation•Mild ocular discomfort
-Burning, FB sensation, irritation
•Localized
• Insidious – over several days•Pain, tenderness to palpation, radiate•Worse at night+awake
Clinical
Episcleritis上強膜炎
• Benign • Self-limiting condition• Simple or nodular• Not a mild version of scleritis• Adult (men=women)• Children (men>women) (1.6:1)
EPIS
CLER
ITI
S
• Acute onset in general• Nodular episcleritis is more insidious • Not much pain at all• May present as hot,prickly and FB like
sensation
EPIS
CLER
ITI
S
Physical examination• VA is usually not affected• Lid edema• Chemosis• Brick red injection, not violaceous• Normal vessels architecture• Topical phenylephrine blanch only
conjunctival vasculature and superficial episcleral capillary plexus
EPIS
CLER
ITI
S
EPIS
CLER
ITI
S
Red brick
Chemosis
injection
Vessel engorgement
EPIS
CLER
ITI
SNodular
InjectionFaint brick red color
Displacing of reflected light
Clinical Course• Simple episcleritis is bilateral in 40% of cases• Nodular episcleritis is bilateral 13% of cases• Two classic presentation
– Peaks 24 after the onset of symptoms and slow improvement develops in 5-10 days, with complete resolution 2-3weeks
– Milder, with more prolonged attacks and no regularity to the intervals between attacks (associated with systemic diseases)
• Nodular episcleritis is more uncomfortable, solitary or multiple lesions which persists for 2 months
EPIS
CLER
ITI
S
Differential diagnosisEP
ISCL
ERIT
IS
Phlyctenular conjunctivitis
Conjunctivitis
Scleritis
pathology• Non-granulomatous inflammation with
vascular dilation and perivascular infiltration of lymphocytes and plasma cells
• Biopsy of episcleral nodules in RA is similar to subcutaneous rheumatoid nodules
EPIS
CLER
ITI
S
complication• Complications are uncommon• If high recurrent rate may lead to
Anterior Uveitis, Intermediate Uveitis, corneal change but these are rare
EPIS
CLER
ITI
S
etiology• Most are idiopathic• 26-36% have an associated disorder• Wegener’s granulomatosis ,Cogan’s
syndrome• Gout is certainly associated with
episcleritis
EPIS
CLER
ITI
S
EPIS
CLER
ITI
S
EPIS
CLER
ITI
S
EPIS
CLER
ITI
S
Laboratory EvaluationEP
ISCL
ERIT
IS
Rheumatoid FactorAntinuclear AntibodySerum uric acidErythrocyte sedimentation rateComplete Blood count with differentialVDRL-FTAUrinalysisPPDChest X-ray film
treatment• May be not necessary• Episcleritis doesn’t progress to scleritis• Treat underlying diseases• Supportive therapy (cold compress, iced artificial tears)• Topical NSAIDs is effective• Amino-Thiazole hydrochloride 0.1% is effective• Topical steroids is dilemma
– Increased risk of recurrent episode– Rebound effect make episcleritis even worse– Start with FML qid is acceptable in just short course
• Oral NSAIDs should be kept for the last
EPIS
CLER
ITI
S
Scleritis強膜炎
• Divided into two major categories
– Non-infectious scleritis (immune-mediated disorders, vasculitides)
– Infectious scleritis (surgery, adjacent organ)
SCLE
RIT
IS
Immune-mediated scleritis• Most common in 40-60 group of age• Women>men 1.6:1• Bilateral 52%• Scleritis have 25-50% chance of harboring a
systemic disease involved– Relapsing polychondritis has 14% chance of
acquired scleritis,– Wegener’s granulomatosis has 10%– IBS has 10%– Polyarteritis nodosa, RA have 6 %SCLE
RIT
IS
Pathogenesis and risk factors• Exact mechanisms are unknown • disordered immune response might play crucial roles
of scleritis• Interaction of genetically controlled mechanisms with
environmental factors or endogenous substances give rise to an autoimmune process that damages the episcleral and scleral perforating capillary and post capillary venules causing inflammatory microangiopathy
• Histopathologic studies suggest that immune complex deposition (type III hypersensitivity) SCLE
RIT
IS
• Scleritis, especially necrotizing scleritis, is more common in those with an underlying systemic vasculitis.
• 96% of patients with surgically-induced scleritis had necrotizing scleritis
• Scleritis has been reported as an adverse side effect of medications, primarily bisphosphonates
SCLE
RIT
IS
Clinical finding• Watson and Hayreh classification
SCLE
RIT
IS
SCLE
RIT
IS
• Diffuse anterior scleritis is the most common clinical presentation and is the least severe type of scleritis
• The sclera often takes on a violet, blue, or salmon color
• After resolution translucent or bluish-gray color
• An associated systemic disease may be found in 25-45% of patients with diffuse anterior scleritis, most commonly RASCLE
RIT
IS
• Nodular anterior scleritis presents with a nodule that is firm, immobile and tender to palpation
• Yellow or deep red
SCLE
RIT
IS
• Of all, necrotizing anterior scleritis with inflammation (necrotizing scleritis) is the most severe and is associated with the greatest potential for visual loss
• Present in extreme discomfort and may be in severe distress
• Examination reveals white, avascular areas of sclera and conjunctiva, with surrounding scleral edema and congestion
• Uveal tissue may appear SCLE
RIT
IS
• Rapidly progressive necrotizing scleritis is often bilateral and associated with an acute exacerbation of systemic vasculitis
• Visual loss is common in necrotizing scleritis and probably more severe with underlying connective tissue disease or vasculitis (WG,RA,Relapsing Polychondritis)
SCLE
RIT
IS
SCLE
RIT
IS Necrotizing scleritisavascular areas
surrounding scleral edema and congestion
Markedly injected surrouding area
• Necrotizing scleritis without inflammation, also termed
scleromalacia perforans, is almost total lack of symptoms
• Patient may present with blurred vision because of astigmatism or may notice a discoloration of the sclera
• In necrotizing scleritis , only conjunctiva may cover prolapsed uvea, but perforation is uncommon without trauma
SCLE
RIT
IS
SCLE
RIT
IS
Necrotizing scleritis without inflammation is most common in elderly women with
long-standing RA
Posterior scleritis• may be difficult to diagnose unless accompanied by anterior scleritis • The condition is under-diagnosed and frequently leads to sight-
threatening complications• About 20% of all cases of scleritis• About 30% of patients have systemic disease
SCLE
RIT
IS
SCLE
RIT
IS• Patients may complain of loss of vision, pain, or diplopia
and findings may include hyperopia, conjunctival chemosis, proptosis, lid edema or retraction, and ophthalmoplegia
• Posterior segments=optic nerve edema, optic neuritis, serous and exudative RD, ME, annular ciliochoroidal detachment and choroidal thickening, mass and folds, all commonly associated with visual loss
Associated systemic diseases
• Most commonly seen in patients with necrotizing scleritis and scleromalacia perforans
• The most common associated disease is RA, WG and relapsing polychondritis respectively
• Necrotizing scleritis in WG is a severe disease that can lead to permanent visual loss
SCLE
RIT
IS
SCLE
RIT
IS
Rheumatoid ArthritisWegener’s granulomatosis
Relapsing Polychondritis
complications• Visual loss• Uveitis
– AU in necrotizing scleritis, PU in posterior scleritis• Keratitis, interstitial keratitis, PUK
– Adjacent peripheral cornea thinning• Glaucoma
– Transient elevated IOP during inflammatory episodes• Cataract
– PSC from inflammation and steroid Rx• Fundus abnormalities
– CME,optic nerve edema, RD, Choroidal foldsSCLE
RIT
IS
• Imaging study– Chest x-ray (TB,sarcoidosis)– Sacroiliac joints film – B-scan ultrasonography (posterior
scleritis)• Thickening of posterior sclera• “T” sign • Fluid in sub-Tenon space at the
junction of the optic nerve and globe
Diagnostic EvaluationSC
LER
ITIS
“T” signSC
LER
ITIS
SCLE
RIT
ISdiffuse thickening of the choroid, sclera and episcleral tissues
The optic disc was swollen
fluid in the subtenon space producing a prominent T-sign
SCLE
RIT
IS
Posterior scleral thickening with proptosis
CT orbit and brain
SCLE
RIT
IS
therapy• NSAIDs oral• Topical steroids and topical NSAIDs• Systemic steroids (1mg/kg/day)• Subconjunctival injections of TA• Intraorbital injection of steroids• MP 2.5-3.0mg/kg IM• Systemic immunosuppressive agents• New biologic agents SCLE
RIT
IS
SCLE
RIT
IS
Infectious scleritis• Classified into two group
– Exogenous is most common (post-trauma,post-surgery) acute,suppurative, and destructive
– Endogenous is less common (syphilis, TB) resemble noninfectious diffuse, nodular, or necrotizing type
• Most commonly, the sclera is infected by migration of organisms from the adjacent cornea in cases of keratitis. But infections of the conjunctiva or orbital tissues almost never involve the scleraSCLE
RIT
IS
SCLE
RIT
IS
• Trauma can introduce organisms directly into the sclera in penetrating injuries
• Foreign Body that pass through the sclera may harbor organisms
• Systemic immunosuppression is a risk factor for infectious scleritisSCLE
RIT
IS
Clinical finding• Keratoscleritis• Panopthalmitis• Scleritis after scleral buckling surgery• Post-pterygium excision scleritis• Other postsurgical infectious scleritis• Herpetic scleritis• Syphilitic scleritis• Mycobacterium tuberculosis scleritisSCLE
RIT
IS
• Keratoscleritis– Most cases of infectious scleritis result from
severe bacterial infections of the cornea– Most are gram negative bacteria
esp.Pseudomonas aeruginosa– Staphylococcus aureus, Sterptococcus
pneumoniae, Mycobacterium chelonei, herpes simplex, herpes zoster, Aspergillus, Acremonium and Acanthamoeba
– Can be more severe in immunosuppressed patientsSC
LER
ITIS
SCLE
RIT
IS
• Panophthalmitis– May result from progression of severe
endopthalmitis of any cause.– Most cases occur after trauma or surgery– First sign of scleral infection may be scleral
thinning, uveal prolapse, or scleral perforation.
– Poor visual prognosis
SCLE
RIT
IS
• Scleritis after scleral buckling surgery– Pain and FB sensation– May develop immediately after surgery, or
years later– Causative genera include staphylococcus,
Pseudomonas, Proteus, and fungi
SCLE
RIT
IS
• Post-pterygium excision scleritis– Rare– Usually associated with the use of
mitomycin-C or beta-irradiation at the excision site.
– Interestingly, infectious scleritis after pterygium surgery can have a long latency period (1-36 years)
– Pain, redness, scleral necrosis and purulent discharge
– P.aeruginosa is the most common organism in postsurgical infectious scleritisSC
LER
ITIS
• Other postsurgical infectious scleritis– Cataract surgery– Strabismus surgery– Glaucoma filtering surgery– vitrectomy
SCLE
RIT
IS
• Herpetic scleritis– Scleral involement in primary varicella
zoster can occur and may be associated with stromal keratitis
SCLE
RIT
IS
• Syphilitic scleritis– Less than 5% of cases of scleritis in a
referral practice– Has been reported with the secondary,
tertiary, and congenital forms of the disease
– Usually have positive serologic tests for tremonema pallidum and usually respond to systemic penicillin or other appropriate antibiotics
SCLE
RIT
IS
• Mycobacterium tuberculosis scleritis– May be asymptomatic or may have pain,
redness, and a mucopurulent discharge.
– Uveitis with corneal opacification and vascularization will often accompany tubercular scleritis
SCLE
RIT
IS
Sign aiding in differential diagnosis
SCLE
RIT
IS
investigation• C/S cornea • History taking • C/S of infected tissues should be performed• G/S, Giemsa stains should be obtained with placement
of scrapings on blood, chocolate and sabourad agar.• If TB is supectedAFB and cultures on Lowenstein-
Jensen Medium• If Acanthamoeba is suspected staining with calcofluor
white or specific Antibodies, and plating on non-nutrient agar over laid with E.coli
• Bx of inflammed sclera is not instantly suggestSCLE
RIT
IS
Therapy• Effective treatment of infectious scleritis usually requires
culture or pathologic evidence of a causative organism• TB IRZE (or streptomycin instead of ethambutol)• Herpes zoster scleritistopical or systemic
corticosteroids, Acyclovir • Syphilitic scleritissystemic penicillin therapy, systemic
or topical steroids• Fungal scleritisprolonged systemic and topial antifungal
therapy• Aspergillus flavus scleritis combination of voriconazole
and caspofunginSCLE
RIT
IS
SCLE
RIT
IS
• Bacterial scleritisbased on G/S,C/Sparenteral therapy is generally accepted
• Pseudomonas scleritis or sclerokeratitiscombination of IV caftazidime and aminoglycoside (tobramycin or gentamicin) + topical Fortified ATB can be effective
• Cryotherapy
• Aggressive surgical debridement of infected tissue with appropiate ATB therapy may further improve response
• Severe destruction of the cornea or scleral perforation may require lamellar or full-thickness grafting.SCLE
RIT
IS
TAKE HOME MESSAGE
ホームメッセージを取ります
Classificationepiscleritis scleritisSimple Anterior scleritis
-nodular type-diffuse type-necrotizing with inflammation-necrotizing without inflammation (Scleromalacia Perforan)
Nodular Posterior scleritis
Episcleritis Scleritis•Abrupt -Days to weeks•Redness without irritation•Mild ocular discomfort
-Burning, FB sensation, irritation
•Localized
• Insidious – over several days•Pain, tenderness to palpation, radiate•Worse at night+awake
Clinical
EPIS
CLER
ITI
S
Clinical finding• Watson and Hayreh classification
SCLE
RIT
IS
Infectious scleritis• Classified into two group
– Exogenous is most common (post-trauma,post-surgery) acute,suppurative, and destructive
– Endogenous is less common (syphilis, TB) resemble noninfectious diffuse, nodular, or necrotizing type
• Most commonly, the sclera is infected by migration of organisms from the adjacent cornea in cases of keratitis. But infections of the conjunctiva or orbital tissues almost never involve the scleraSCLE
RIT
IS
• Diffuse anterior scleritis is the most common clinical presentation and is the least severe type of scleritis
• An associated systemic disease may be found in 25-45% of patients with diffuse anterior scleritis, most commonly RA
SCLE
RIT
IS
“T” signSC
LER
ITIS
Posterior scleritis
SCLE
RIT
IS